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SCIENTIFIC OPINION 
Scientific Opinion on Flavouring Group Evaluation 216, Revision 1 
(FGE.216Rev1). Consideration of genotoxic potential for α,β-unsaturated 2-
Phenyl -2-Alkenals from Subgroup 3.3 of FGE.19 1
EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
(CEF)
 
2, 3
European Food Safety Authority (EFSA), Parma, Italy 
 
 
ABSTRACT 
The Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids of the European Food Safety 
Authority was requested to evaluate the genotoxic potential of five flavouring substances from subgroup 3.3 of 
FGE.19. In the Flavouring Group Evaluation 216 (FGE.216) additional genotoxicity data were requested. 
Additional genotoxicity studies have now been provided for the representative substance 2-
phenylcrotonaldehyde [FL-no: 05.062]. Based on these new data the Panel concluded that the concern for 
genotoxicity could not be ruled out and requests a proof of sufficient systemic exposure of animals treated with 
2-phenylcrotonaldehyde. Moreover, since the substance was genotoxic only without metabolic activation, it 
appears necessary to prove the absence of genotoxic effect locally in the gastro intestinal system using the Comet 
assay. 
© European Food Safety Authority, 2013 
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SUMMARY 
Following a request from the European Commission the Panel on Food Contact Materials, Enzymes, 
Flavourings and Processing Aids (CEF Panel) was asked to deliver a scientific opinion on the 
implications for human health of chemically defined flavouring substances used in or on foodstuffs in 
the Member States. In particular, the Panel was asked to evaluate 5 flavouring substances in 
Flavouring Group Evaluation 216 (FGE.216) using the Procedure as referred to in the Commission 
Regulation (EC) No 1565/2000.  
The FGE.216 concerned five α,β-unsaturated 2-phenyl substituted aldehydes, 2-phenylcrotonaldehyde 
[FL-no: 05.062], 5-methyl-2-phenylhex-2-enal [FL-no: 05.099], 4-methyl-2-phenylpent-2-enal [FL-
no:  05.100], 2-phenylpent-2-enal [FL-no: 05.175] and 2-phenyl-4-methyl-2-hexenal [FL-no: 05.222], 
corresponding to subgroup 3.3 of FGE.19.  The conclusion of the Panel in FGE.216 was that the 
available data on genotoxicity were too limited to evaluate the five substances through the Procedure 
and additional genotoxicity studies were requested. 
The Flavouring Industry has now submitted new data in reply to the above requested data for FGE.19 
subgroup 3.3 (FGE.216) for the representative flavouring substance, 2-phenylcrotonaldehyde [FL-no: 
05.062], covering the remaining four substances [FL-no: 05.099, 05.100, 05.175 and 05.222].   
Based on these new data, the Panel concluded that the concern for genotoxicity could not be ruled out 
and requests a proof of sufficient systemic exposure of animals treated with 2-phenylcrotonaldehyde. 
Moreover, since the substance was genotoxic only without metabolic activation, it appears necessary 
to prove the absence of genotoxic effect locally in the gastrointestinal system using the Comet assay.  
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION 
The use of flavourings is regulated under Regulation (EC) No 1334/2008 of the European Parliament 
and Council of 16 December 2008 on flavourings and certain food ingredients with flavouring 
properties for use in and on foods. On the basis of article 9(a) of this Regulation an evaluation and 
approval are required for flavouring substances. 
The Union List of flavourings and source materials was established by Commission Implementing 
Regulation (EC) No 872/2012. The list contains flavouring substances for which the scientific 
evaluation should be completed in accordance with Commission Regulation (EC) No 1565/2000. 
EFSA has evaluated five flavouring substances, which correspond to subgroup 3.3 of FGE.19, in its 
evaluation of the flavouring group 216 (FGE.216). The opinion was adopted on 27 November 2008. 
The Panel concluded that a genotoxic potential of the five 2-phenyl-substituted aldehydes (i.e. 2-
phenyl-2-alkenals) in the present FGE.216 could not be ruled out. 
Information on one representative material, 2-phenylcrotonaldehyde [FL-no: 05.062], has now been 
submitted by the European Flavour Association. This information is intended to cover the re-
evaluation of this substance and of the following four substances from FGE.19 subgroup 3.3: 
• 5-Methyl-2-phenylhex-2-enal [FL-no: 05.099] 
• 4-Methyl-2-phenylpent-2-enal [FL-no:  05.100] 
• 2-Phenylpent-2-enal [FL-no: 05.175] 
• 2-Phenyl-4-methyl-2-hexenal [FL-no: 05.222] 
The commission asks EFSA to evaluate this new information and depending on the outcome proceed 
to the full evaluation of the flavouring substances. 
 
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
The European Commission requests the European Food Safety Authority to carry out a safety 
assessment on the following five substances: 2-phenylcrotonaldehyde [FL-no: 05.062], 5-methyl-2-
phenylhex-2-enal [FL-no: 05.099], 4-methyl-2-phenylpent-2-enal [FL-no:  05.100], 2-phenylpent-2-
enal [FL-no: 05.175] and 2-phenyl-4-methyl-2-hexenal [FL-no: 05.222] in accordance with 
Commission Regulation (EC) No 1565/2000. 
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HISTORY 
Regulation (EC) No 2232/96 of the European Parliament and the Council (EC, 1996) lays down a 
Procedure for the establishment of a list of flavouring substances, the use of which will be authorised 
to the exclusion of all other substances in the EU. In application of that Regulation, a Register of 
flavouring substances used in or on foodstuffs in the Member States was adopted by Commission 
Decision 1999/217/EC (EC, 1999), as last amended by Commission Decision 2009/163/EC (EC, 
2009). Each flavouring substance is attributed a FLAVIS-number (FL-number) and all substances are 
divided into 34 chemical groups. Substances within a group should have some metabolic and 
biological behaviour in common. 
Substances which are listed in the Register are to be evaluated according to the evaluation programme 
laid down in Commission Regulation (EC) No 1565/2000 (EC, 2000), which is broadly based on the 
opinion of the Scientific Committee on Food (SCF, 1999). For the submission of data by the 
manufacturer, deadlines have been established by Commission Regulation (EC) No 622/2002 (EC, 
2002).  
The Union list of flavourings and source materials is established in Commission Regulation (EC) No 
872/2012 (EC, 2012). 
Flavouring Group Evaluation 19 (FGE.19) contains 360 flavouring substances from the EU Register 
being α,β-unsaturated aldehydes or ketones and precursors which could give rise to such carbonyl 
substances via hydrolysis and/or oxidation (EFSA, 2008a). 
The α,β-unsaturated aldehyde and ketone structures are structural alerts for genotoxicity. The Panel 
noted that there were limited genotoxicity data on these flavouring substances but that positive 
genotoxicity studies were identified for some substances in the group. 
The α,β-unsaturated carbonyls were subdivided into subgroups on the basis of structural similarity 
(EFSA, 2008a). In an attempt to decide which of the substances could go through the Procedure, a 
(quantitative) structure-activity relationship (Q)SAR prediction of the genotoxicity of these substances 
was undertaken considering a number of models (DEREKfW, TOPKAT, DTU-NFI-MultiCASE 
Models and ISS-Local Models, (Gry et al., 2007)). 
The Panel noted that for most of these models internal and external validation has been performed, but 
considered that the outcome of these validations was not always extensive enough to appreciate the 
validity of the predictions of these models for these α,β-unsaturated carbonyls. Therefore, the Panel 
considered it inappropriate to totally rely on (Q)SAR predictions at this point in time and decided not 
to take substances through the Procedure based on negative (Q)SAR predictions only. 
The Panel took note of the (Q)SAR predictions by using two ISS Local Models (Benigni and Netzeva, 
2007) and four DTU-NFI MultiCASE Models (Gry et al., 2007; Nikolov et al., 2007) and the fact that 
there are available data on genotoxicity, in vitro and in vivo, as well as data on carcinogenicity for 
several substances. The Panel decided that 11 subgroups (1.1.2, 1.1.3, 1.1.4, 2.4, 2.6, 2.7, 3.1, 3.3, 4.1, 
4.2 and 4.4) of FGE.19 (EFSA, 2008a) should be further examined to determine whether evaluation 
through the Procedure is feasible. Corresponding to these 11 subgroups, 11 Flavouring Group 
Evaluations (FGEs) were established (FGE.201, 202, 203, 210, 212, 213, 214, 216, 217, 218 and 220). 
If the Panel concludes for any substances in these 11 FGEs that they cannot be evaluated using the 
Procedure, then it has to be decided if there is a safety concern for certain substances or if additional 
data are required in order to finalise the evaluation. If the Panel concludes that a genotoxic potential 
can be ruled out for the substances, they will be merged with structurally related substances in other 
FGEs and evaluated using the Procedure. 
To ease the data retrieval of the large number of structurally related α,β-unsaturated substances in the 
different subgroups for which additional data are requested, EFSA has worked out a list of 
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representative substances for each subgroup (EFSA, 2008c). Likewise, an EFSA genotoxicity expert 
group has worked out a test strategy to be followed in the data retrieval for these substances (EFSA, 
2008b).  
The Flavouring Industry has been requested to submit additional genotoxicity data according to the list 
of representative substances and test strategy for each subgroup.  
The Flavouring Industry has now submitted additional data and the present revision of FGE.216 
concerns the evaluation of these data requested on genotoxicity. 
PRESENTATION OF THE SUBSTANCES BELONGING TO THE FLAVOURING GROUP 
EVALUATION 216 CORRESPONDING TO FGE.19 SUBGROUP 3.3 
The Flavouring Group Evaluation 216 (FGE.216) concerns five α,β-unsaturated 2-phenyl substituted 
aldehydes, 2-phenylcrotonaldehyde [FL-no: 05.062], 5-methyl-2-phenylhex-2-enal [FL-no: 05.099], 4-
methyl-2-phenylpent-2-enal [FL-no:  05.100], 2-phenylpent-2-enal [FL-no: 05.175] and 2-phenyl-4-
methyl-2-hexenal [FL-no: 05.222], which are presented in Table 1. The five substances correspond to 
subgroup 3.3 of FGE.19.  
The α,β-unsaturated aldehyde and ketone structures are structural alerts for genotoxicity (EFSA, 
2008a). Accordingly, the available data on genotoxic or carcinogenic activity for the five aldehydes 
[FL-no: 05.062, 05.099, 05.100, 05.175 and 05.222] will be considered in this FGE. 
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SPECIFICATION SUMMARY OF THE SUBSTANCES IN THE FLAVOURING GROUP EVALUATION 216REV1  
Table 1:  Specification Summary of the Substances in the Flavouring Group Evaluation 216Rev1 
FL-no 
JECFA-no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 2) 
Boiling point, °C 3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 4) 
Spec.gravity 5) 
05.062 
1474 
2-Phenylcrotonaldehyde 
O  
3224 
670 
4411-89-6 
 
C10H10O 
146.19 
 
 
177 (20 hPa) 
 
NMR 
97 % 
1.558-1.564 
1.031-1.037 
05.099 
1472 
5-Methyl-2-phenylhex-2-enal 
O
 
3199 
10365 
21834-92-4 
Liquid 
C13H16O 
188.27 
 
 
96-100 (0.9hPa) 
 
NMR 
96 % 
1.531-1.536 
0.970-0.976 
05.100 
1473 
4-Methyl-2-phenylpent-2-enal 
O  
3200 
10366 
26643-91-4 
Liquid 
C12H14O 
174.24 
 
 
96 (0.9 hPa) 
 
NMR 
95 % 
1.533-1.539 
0.980-0.986 
05.175 
 
2-Phenylpent-2-enal   6) O
 
 
 
3491-63-2 
Liquid 
C11H12O 
160.22 
Practically insoluble or 
insoluble 
Freely soluble 
126 (15 hPa) 
 
MS 
95 % 
1.545-1.553 
1.005-1.015 
05.222 
 
2-Phenyl-4-methyl-2-hexenal 
O  
4194 
 
26643-92-5 
Liquid 
C13H16O 
188 
Insoluble 
Soluble 
97 (0.6 hPa) 
 
 
95 % 
1.522-1.530 
0.965-0.975 
1) Solubility in water, if not otherwise stated. 
2) Solubility in 95 % ethanol, if not otherwise stated. 
3) At 1013.25 hPa, if not otherwise stated. 
4) At 20°C, if not otherwise stated. 
5) At 25°C, if not otherwise stated. 
Flavouring Group Evaluation 216Rev1 
 
EFSA Journal 2013;11(7):3305 8 
ASSESSMENT 
1. History of the FGE.216 Evaluation  
In the first scientific opinion on FGE.216 (EFSA,2009), the Panel concluded that a genotoxic potential 
of the five 2-phenyl-substituted aldehydes (i.e. 2-phenyl-2-alkenals) could not be ruled out and 
therefore the five substances could not be evaluated through the Procedure. Additional data on 
genotoxicity for representative substances of this subgroup should be provided, according to the 
Genotoxicity Test Strategy for Substances Belonging to Subgroups of FGE.19 (EFSA, 2008b).  
In the EFSA Opinion “List of α,β-unsaturated aldehydes and ketones representative of FGE.19 
substances for genotoxicity testing” (EFSA, 2008c), a representative flavouring substance has been 
selected for FGE.19, subgroup 3.3, corresponding to FGE.216. The representative substance is 2-
phenylcrotonaldehyde [FL-no: 05.062] (Table 2). 
Table 2:  Representative substance for subgroup 3.3 of FGE.19 (EFSA, 2008c) 
FL-no  
JECFA-no  
Subgroup  EU Register name  Structural formula  Comments  
05.062 
 
3.3  2-Phenylcrotonaldehyde 
 O  
Data submitted in 
accordance to request in 
FGE.216 
 
The Panel viewed the previous JEFCA evaluation (JECFA, 2006) and reached the conclusions  based 
on the data available at that time. These included a (Q)SAR Prediction analysis (Table 4). No data 
from genotoxicity or carcinogenicity studies with any of the substances in FGE.216 were available.  
 
In Table 4, the outcome of the (Q)SAR predictions for possible genotoxic activity in the five in vitro 
(Q)SAR models (ISS Local Model-Ames test, DTU-NFI MultiCASE-Ames test, -Chromosomal 
aberration test in Chinese hamster ovary cells (CHO), Chromosomal aberration test in Chinese 
hamster lung cells (CHL), and Mouse lymphoma test) are presented. 
The data available were insufficient to rule out the concern for genotoxicity. 
 
 
 
2. Additional Genotoxicity Data Submitted for FGE.19, subgroup 3.3 
The present revision of FGE.216, Revision 1 (FGE.216Rev1) concerns the evaluation of new 
genotoxicity data submitted by European Flavour and Fragrance Association (EFFA), in response to 
the request by EFSA in FGE.216, for the representative substance 2-phenylcrotonaldehyde [FL-no: 
05.062], which is supposed to cover the genotoxicity evaluation of the four other substances in 
FGE.19, subgroup 3.3, 5-methyl-2-phenylhex-2-enal [FL-no: 05.099], 4-methyl-2-phenylpent-2-enal 
[FL-no:  05.100], 2-phenylpent-2-enal [FL-no: 05.175] and 2-phenyl-4-methyl-2-hexenal [FL-no: 
05.222].  
GE Adopted by EFSA Link No. of 
Substances 
FGE.216 27 November 2008 http://www.efsa.europa.eu/en/efsajournal/doc/881.pdf 5 
FGE.216Rev1 4 July 2013  5 
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The new data submitted covers in vitro assays in bacteria and mammalian cell systems and in vivo data 
in the rat. 
2.1. In vitro data 
2.1.1. Bacterial Reverse Mutation Assay 
Ames assays were conducted in Salmonella typhimurium strains TA98, TA100, TA1535, TA1537 and 
TA102 to assess the mutagenicity of 2-phenylcrotonaldehyde [FL-no: 05.062] (98.1 % sum of 
isomers), both in the absence and in the presence of metabolic activation by an Aroclor 1254-induced 
rat liver post-mitochondrial fraction (S9-mix) in three separate assays using both standard plate 
incorporation and modified pre-incubation treatments (Kilford, 2010). The protocol followed OECD 
Test Guideline 471 (OECD, 1997a) and the study was performed according to GLP. 
In assay 1, no increases in revertant numbers were observed when S. typhimurium strains TA98, 
TA100, TA1535, TA1537 and TA102 were incubated with 2-phenylcrotonaldehyde [FL-no: 05.062] 
up to 5000 μg/plate in the absence and presence of S9-mix using the standard plate incorporation 
method. A weak to moderate bacteriostatic activity was noted at concentrations of 1000 μg/plate and 
above in strains TA98 and TA102 in the absence of S9-mix and in strains TA1537 and TA102 in the 
presence of S9-mix. 
In assay 2, no increases in revertant numbers were observed when S. typhimurium strains TA98, 
TA100, TA1535, TA1537 and TA102 were treated with 2-phenylcrotonaldehyde [FL-no: 05.062] up 
to 5000 μg/plate in the absence of S9-mix. In the presence of S9-mix, the same concentrations were 
tested on strains TA98, TA100 and TA1535, whereas TA1537 and TA102 were treated up to 2000 
μg/plate due to an excessive level of cytotoxicity in the first assay. A marked reduction in revertant 
numbers and/or slight thinning of the bacterial lawn was noted in all the high doses tested. No increase 
of revertants was observed except in the treatments of the TA100 strain in the absence of S9-mix at a 
concentration of 2000 μg/plate and in the presence of S9-mix at a concentration of 320 μg/plate. The 
increase in revertant mutations was statistically significant (p < 0.01), but these results were isolated 
and not reproducible in further assays. 
To further explore the increase in mutations seen only in S. typhimurium strain TA100, assay 3 was 
performed in all tester strains in the presence of S9-mix and in the absence of S9-mix in strain TA100. 
No mutagenic effect was demonstrated. 
Under these conditions, 2-phenylcrotonaldehyde [FL-no: 05.062] demonstrated no mutagenic activity 
in S. typhimurium strains TA98, TA100, TA1535, TA1537 and TA102 both in the absence and in the 
presence of metabolic activation. 
2.1.2. Micronucleus assays 
2-Phenylcrotonaldehyde [FL-no: 05.062] was tested to determine its clastogenic or aneugenic potential 
in mammalian cells in vitro using the micronucleus test in cultured human peripheral blood 
lymphocytes with and without metabolic activation (Lloyd, 2012). The test was performed according 
the OECD Test Guideline 487 (OECD, 2010) (except that the assay with metabolic activation was not 
repeated) and performed according to GLP Guidelines. 
The range of doses was determined in a preliminary range finding study.  
In assay 1, 2-phenylcrotonaldehyde [FL-no: 05.062] was added for 3 hours with a 21 hours recovery 
period in the absence of S9-mix and examined at concentrations of 40, 60, 100 and 120 μg/mL. The 
frequency of MNBN cells was statistically higher (p < 0.001) than vehicle controls at 100 and 120 
μg/mL with 26 and 66 % of cytotoxicity, respectively. The frequencies of MNBN cells exceeded the 
95th percentile observed range only at 120 μg/mL (in both cultures), indicating a weak but significant 
induction of chromosomal damage. It was also added to cultures for 3 hours with 21 hours recovery in 
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the presence of S9-mix at concentrations of 100, 130 and 140 μg/mL. The frequency of MNBN cells 
were significantly higher (p < 0.05) at the two highest concentrations analysed, 130 and 140 μg/mL, 
but fell clearly within normal ranges based on historical control data. Cultures were also treated for 24 
+ 0 hours in the absence of S9-mix at concentrations of 20, 23 and 26 μg/mL in the absence of S9-mix. 
The frequencies of MNBN cells were significantly higher (p < 0.05) than those observed in concurrent 
vehicle controls at all three concentrations (20, 23 and 26 μg/mL), but also fell within normal ranges 
based on historical control data. These data were considered difficult to interpret due to the steep 
concentration related cytotoxicity that was observed under all three treatment conditions as indicated 
by decreases in the replication index values of 13, 25 and 43 %, respectively. 
In assay 2, cultures were treated with 2-phenylcrotonaldehyde [FL-no: 05.062] at concentrations of 20, 
60, 70 and 80 μg/mL for 3 hours with 21 hours recovery in the absence of S9-mix. The frequency of 
MNBN cells was significantly higher (p < 0.01) compared to those observed in concurrent vehicle 
controls at 20, 70 and 80 μg/mL, but not at 60 μg/mL. The MNBN cell frequencies in both cultures at 
20 and 70 μg/mL and in one culture at 80 μg/mL exceeded the 95th percentile of the historical control 
range. These observations indicate the induction of micronuclei at concentrations at or below the limit 
of cytotoxicity. 
No second assay was performed with S9-mix. 
In conclusion, 2-phenylcrotonaldehyde [FL-no: 05.062] induced a significant increase of micronuclei 
in cultured human peripheral blood lymphocytes when tested for 3 + 21 hours in the absence of rat 
liver metabolic activation (S9-mix). In the same test system, 2-phenylcrotonaldehyde did not induce 
micronuclei when tested up to toxic concentrations for 3 + 21 hours in the presence of S9-mix and for 
24 + 0 hours in the absence of S9-mix. 
A summary of the in vitro data are presented in Table 5. 
2.2. In vivo data 
2.2.1. Bone Marrow Micronucleus Induction Assay in the rat 
An in vivo micronucleus assay in rats was performed in compliance with OECD Test Guideline 474 
(OECD, 1997b) (Henderson, 2012) to determine whether the results obtained in the initial in vitro 
micronucleus assay reflect the situation in vivo. 
An initial Range-Finding study was conducted in Han-Wistar rats to estimate the Maximum Tolerated 
Dose (MTD) of 2-phenylcrotonaldehyde [FL-no: 05.062], administered by oral gavage. The dose of 
700 mg/kg body weight (bw)/day was selected as the MTD based on displayed toxicity at the higher 
dose levels. 
Groups of six male Han-Wistar rats were treated via gavage with 2-phenylcrotonaldehyde [FL-no: 
05.062] at doses of 0 (vehicle control), 70, 350 and 700 mg/kg bw/day. Animals were dosed at 0 and 
24 hours, followed by sacrifice and harvest of the femoral bone marrow at 24 hours after the last 
treatment. 
Rats treated with 2-phenylcrotonaldehyde [FL-no: 05.062] at all doses exhibited group mean % of 
PCE that were similar to the vehicle control group. This parameter cannot be used to demonstrate 
systemic exposure of animals. 
In rats treated with 2-phenylcrotonaldehyde [FL-no: 05.062] there were no statistically significant 
increases in micronucleus frequency for any of the groups receiving the test article, compared to the 
concurrent vehicle control, with the exception of the intermediate dose group, which was nonetheless 
well within the historic control range and the difference was due to the very low concurrent control 
frequencies. 
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The authors of the report concluded that 2-phenylcrotonaldehyde [FL-no: 05.062] did not induce 
micronuclei in the polychromatic erythrocytes of the bone marrow of male rats treated at 70 and 700 
mg/kg bw/day but that it induced a small statistically significant increase in MN PCE observed at the 
intermediate dose (350 mg/kg bw/day), and they concluded that the small increase observed at 350 
mg/kg bw/day is of questionable biological relevance. The intermediate dose produced a group mean 
MN frequency that was two fold greater than and statistically (p < 0.05) higher than the vehicle control 
group. The mean value (2.83 MN/2000 PCE) was well within the laboratory’s historical range (0.74 - 
4.46 MN/2000 PCE). However, individual results of the first reading demonstrated that MN frequency 
of 4 out of the 6 treated animals exceed the 95 % confidence interval for mean of historical controls 
and all the individual values of the control animals were within the limit of historical controls. 
The data generated from a second set of 2000 PCE gave a similar response across all test article 
groups with all individual values falling ‘normally’ within the historical distribution. However, the 
concurrent vehicle control frequencies were distributed at the low end of the historical data producing 
a low background level for comparison. 
The values obtained in this second reading were: 
% MNPCE 
 Reading 1 Reading 2 Reading mean 
Vehicle 0.10 0.04 0.07 
75 mg/kg 0.09 0.12 0.10 
350 mg/kg 0.18* 0.10 0.14*  
700 mg/kg 0.12 0.12 0.12  
* P < 0.01 
The results demonstrate that after a second reading the increase is still significant when the second 
reading are pooled. 
Plasma of animals of a satellite group were taken but not analysed for 2-phenylcrotonaldehyde [FL-no: 
05.062] content. Under these conditions no clear proof of exposure was given. 
Moreover, the product 2-phenylcrotonaldehyde [FL-no: 05.062] was found to be positive without 
activation in the in vitro micronucleus test, i.e. after oral absorption, the gastrointestinal tract is the 
organ most exposed to high concentrations, which will not be found after systemic passage at the 
medullary level. Under these conditions, it appears necessary to have information of genotoxic 
potential of the product 2-phenylcrotonaldehyde [FL-no: 05.062] in the gastrointestinal mucosa by a 
Comet assay in the stomach or duodenum. 
A summary of the in vivo data are presented in Table 6. 
 
3. Conclusion 
The FGE.216 concerned five α,β-unsaturated 2-phenyl substituted aldehydes, 2-phenylcrotonaldehyde 
[FL-no: 05.062], 5-methyl-2-phenylhex-2-enal [FL-no: 05.099], 4-methyl-2-phenylpent-2-enal [FL-
no:  05.100], 2-phenylpent-2-enal [FL-no: 05.175] and 2-phenyl-4-methyl-2-hexenal [FL-no: 05.222], 
corresponding to subgroup 3.3 of FGE.19.  The conclusion of the Panel in FGE.216 was that the 
available data on genotoxicity were too limited to evaluate the five substances through the Procedure 
and additional genotoxicity data were requested. 
The Flavouring Industry has now submitted new data in reply to the above requested data for FGE.19 
subgroup 3.3 (FGE.216) for the representative flavouring substance, 2-phenylcrotonaldehyde [FL-no: 
05.062], covering the remaining four substances [FL-no: 05.099, 05.100, 05.175 and 05.222].   
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The product 2-phenylcrotonaldehyde [FL-no: 05.062] did not demonstrate any mutagenic effect in a 
bacterial test with and without metabolic activation. However, it showed a genotoxic effect in the in 
vitro micronucleus test in cultured human lymphocytes in the absence of metabolic activation. 
In order to verify that this genotoxic potential demonstrated in vitro was confirmed in vivo, a 
micronucleus test was conducted in the rat bone marrow by oral route which led to an ambiguous 
result, because only the intermediate dose induced a statistically significant increase of MNPCE, even 
after rereading the slides. No evidence of systemic exposure of animals was provided in this study, in 
particular, no change in the percentage of PCE in the bone marrow was noted and plasma of animals 
sampled in a satellite group have not been analysed. 
Under these conditions it appears necessary to provide proof of sufficient systemic exposure of 
animals treated with 2-phenylcrotonaldehyde. 
Moreover, since the substance was genotoxic only without metabolic activation, it appears necessary 
to prove the absence of genotoxic effect locally in the gastrointestinal system using the Comet assay. 
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SUMMARY OF SAFETY EVALUATION APPLYING THE PROCEDURE (BASED ON THE MSDI APPROACH) 
Table 3:  Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) (JECFA, 2006) 
FL-no 
JECFA-no 
EU Register name Structural formula MSDI 1) 
(µg/capita/day) 
Class 2) 
Evaluation procedure path 3) 
(JECFA) 
Outcome on the 
named compound 
[ 4) or 5] 
EFSA comments 
05.062 
1474 
2-Phenylcrotonaldehyde 
O  
1.7 
0.07 
Class I 
A3: Intake below threshold 
4) Evaluated in FGE.216Rev1, 
additional genotoxicity data 
required. 
05.099 
1472 
5-Methyl-2-phenylhex-2-enal 
O
 
15 
6 
Class II 
A3: Intake below threshold 
4) Evaluated in FGE.216Rev1, 
additional genotoxicity data 
required. 
05.100 
1473 
4-Methyl-2-phenylpent-2-enal 
O  
0.34 
5 
Class II 
A3: Intake below threshold 
4) Evaluated in FGE.216Rev1, 
additional genotoxicity data 
required. 
05.175 
 
2-Phenylpent-2-enal O
 
0.011 
 
Class II 
No evaluation 
Not evaluated by 
JECFA 
Evaluated in FGE.216Rev1, 
additional genotoxicity data 
required. 
05.222 
 
2-Phenyl-4-methyl-2-hexenal 
O  
3.0 
 
 
No evaluation 
Not evaluated by 
JECFA 
Evaluated in FGE.216Rev1, 
additional genotoxicity data 
required. 
1) EU MSDI: Amount added to food as flavour in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day. 
2) Thresholds of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day. 
3) Procedure path A substances can be predicted to be metabolised to innocuous products.  Procedure path B substances cannot. 
4) No safety concern based on intake calculated by the MSDI approach of the named compound. 
5) Data must be available on the substance or closely related substances to perform a safety evaluation. 
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QSAR PREDICTIONS ON MUTAGENICITY IN FIVE MODELS FOR FIVE ALDEHYDES FROM SUBGROUP 3.3 
Table 4:  QSAR Predictions on Mutagenicity for Five Aldehydes from Subgroup 3.3 
FL-no 
JECFA-no 
Sub- 
group 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
ISS Local Model 
Ames Test TA100 
 
MultiCASE  
Ames test 
  
MultiCASE 
Mouse lymphoma 
test 
MultiCASE 
Chromosomal 
aberration test in 
CHO 
MultiCASE 
Chromosomal 
aberration test in 
CHL 
05.062 
1474 
3.3 2-Phenylcrotonaldehyde 
O  
3224 
670 
4411-89-6 
NEG OD OD OD OD 
05.099 
1472 
3.3 5-Methyl-2-phenylhex-2-enal 
O
 
3199 
10365 
21834-92-4 NEG OD OD OD OD 
05.100 
1473 
3.3 4-Methyl-2-phenylpent-2-enal 
O  
3200 
10366 
26643-91-4 
NEG OD OD OD OD 
05.175 
 
3.3 2-Phenylpent-2-enal   6) O
 
- 
- 
3491-63-2 NEG OD OD OD OD 
05.222 
 
3.3 2-Phenyl-4-methyl-2-hexenal 
O  
- 
- 
26643-92-5 NEG OD OD OD OD 
Column 2: Structure group 4.4: α,β-unsaturated ketones.  
Column 6: Local model on aldehydes and ketones, Ames TA100. (NEG: Negative; POS: Positive; OD*: out of domain). 
Column 7: MultiCase Ames test (OD*: Out of domain; POS: Positive; NEG: Negative; EQU: Equivocal). 
Column 8: MultiCase Mouse Lymphona test (OD*: Out of domain; POS: Positive; NEG: Negative; EQU: Equivocal). 
Column 9: MultiCase Chromosomal aberration in CHO (OD*: Out of domain; POS: Positive; NEG: Negative; EQU: Equivocal). 
Column 10: MultiCase Chromosomal aberration in CHL (OD*: Out of domain; POS: Positive; NEG: Negative; EQU: Equivocal). 
* OD, out of applicability domain: not matching the range of conditions where a reliable prediction can be obtained in this model. These conditions may be physicochemical, structural, biological etc. 
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SUMMARY OF ADDITIONAL GENOTOXICITY DATA ON 2-PHENYLCROTONALDEHYDE [FL-NO: 05.062] SUBMITTED BY INDUSTRY 
Table 5:  Summary of Additionally submitted genotoxicity data on [FL-no: 05.062] of subgroup 3.3 (in vitro) 
FL-no Chemical Name Test System in 
vitro  
Test Object  Concentrations of 
Substance and Test 
Conditions  
Result  Reference  Comments  
[05.062] 2-Phenylcrotonaldehyde Reverse 
Mutation 
S. typhimurium 
TA98, TA100, TA1535, 
TA1537 and TA102 
 
1.6, 8, 40, 200, 1000 and 
5000 μg/plate [1,2] 
Negative (Kilford, 2010) Toxicity was observed in all strains at 5000 μg/plate in the 
absence and presence of S9, and at 1000 μg/plate and 
above in strains TA98 and TA102 in the absence of S9 
and in strains TA1537 and TA102 in the presence of S9. 
All strains were negative. Study design complied with 
current recommendations. Acceptable top concentration 
was achieved. 
S. typhimurium 
TA98, TA100, TA1535 
TA1537 and TA102 
 
 
20.48, 51.2, 128, 320, 800, 
2000 and 5000 μg/plate 
[2,4] 
 
Negative 
 
 
 
(Kilford, 2010) Toxicity was observed in strains TA1537 and TA102 at 
2000 μg/plate and above in the absence of S9 and at 320 
μg/plate in the presence of S9. Similar toxicity was also 
observed in strains TA98, TA100 and TA1535 at 5000 
μg/plate in the absence of S9 and at 800 μg/plate and 
above in the presence of S9. Statistically significant 
differences in mutation frequency were observed only in 
strain TA100 and only at levels of toxicity (in the absence 
of S9-mix at a concentration of 2000 μg/plate and in the 
presence of S9-mix at 320 μg/plate). Study design 
complied with current recommendations. Acceptable top 
concentration was achieved. 
S. typhimurium 
TA98, TA100*, TA1535  
 
 
51.2, 128, 320, 800, 2000 
and 5000 μg/plate [3,5] 
 
Negative 
 
 
S. typhimuriumTA1537 
and TA102  
 
 
 
51.2, 128, 320, 800, 2000 
μg/plate [3,5] 
 
 
Negative 
 
S. typhimurium 
TA98, TA100, TA1535  
 
31.25 - 1000 μg/plate [3,5] 
 
 
Negative (Kilford, 2010) Toxicity was observed at 3500 μg/plate and above in 
strain TA100 in the absence of S9. In the presence of S9, 
toxicity was observed at 250 μg/plate and above in strains 
TA1537 and TA102 and at 1000 μg/plate and above in 
strains TA100, TA98 and TA1535. S. typhimurium 
TA1537, TA102 
 
 
15.625 - 500 μg/plate [3,5] 
 
Negative 
 
S. typhimurium 
TA100 
 
 
 
320 - 5000 μg/plate [2,4] 
 
 
 
 
 
 
 
Negative 
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Table 5:  Summary of Additionally submitted genotoxicity data on [FL-no: 05.062] of subgroup 3.3 (in vitro) 
FL-no Chemical Name Test System in 
vitro  
Test Object  Concentrations of 
Substance and Test 
Conditions  
Result  Reference  Comments  
Micronucleus 
induction 
Human peripheral 
blood lymphocytes 
40, 60, 100, 120 
μg/mL [4,6] 
 
 
Positive (Lloyd, 2012) The MNBN cell frequencies increases were statistically 
significant at the top two concentrations but only slightly 
exceeded the 95% range of historic controls at the highest 
dose. All other treated cultures fell within the normal 
range. The study complies with OECD Test Guideline 
487 (OECD, 2010). 
100, 130, 140 μg/mL [5.6] 
 
20, 23, 26 μg/mL [4,7] 
Negative 
 
 
Negative 
(Lloyd, 2012) The MNBN cell frequencies increases were statistically 
significant at the top two concentrations but all treated 
cultures fell within the normal range. The study complies 
with OECD Test Guideline 487 (OECD, 2010). 
20, 60, 70 and 80 μg/mL 
[4,6] 
Positive (Lloyd, 2012) The MNBN cell frequencies in both cultures at 20 and 70 
μg/mL and in one culture at 80 μg/mL exceeded the 95th 
percentile of the historical control range. The study 
complies with OECD Test Guideline 487 (OECD, 2010). 
[1] With and without S9 metabolic activation. 
[2] Plate incorporation method. 
[3] Pre-incubation method. 
[4] Without S9 metabolic activation. 
[5] With S9 metabolic activation. 
[6] 3-hour incubation with 21-hour recovery period. 
[7] 24-hour incubation with no recovery period. 
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Table 6:  Summary of Additionally Genotoxicity Data [FL-no: 05.062] of Subgroup 3.3 (in vivo) 
FL-no Chemical Name Test System in 
vivo  
Test Object  
Route 
Concentrations of 
Substance and Test 
Conditions  
Result  Reference  Comments  
[05.062] 2-Phenylcrotonaldehyde Micronucleus 
induction 
Rat 
Gavage 
70, 350, and 700 
mg/kg bw/day 
Negative (Henderson, 2012) The study complies with OECD Test Guideline 474 
(OECD, 1997b). Acceptable levels of cytotoxicity 
achieved at the top concentrations used. 
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ABBREVIATIONS 
BW  Body Weight 
CAS  Chemical Abstract Service 
CEF Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
Chemical Abstract Service 
CHO  Chinese hamster ovary (cells) 
CHL  Chinese hamster lung (cells) 
CoE  Council of Europe 
EC  European Commission 
EFFA  European Flavour and Fragrance Association 
EFSA  The European Food Safety Authority 
EU  European Union 
FAO  Food and Agriculture Organization of the United Nations  
FEMA  Flavor and Extract Manufacturers Association 
FGE  Flavouring Group Evaluation  
FLAVIS (FL) Flavour Information System (database) 
GLP  Good Laboratory Practice 
ID   Identity 
JECFA  The Joint FAO/WHO Expert Committee on Food Additives 
MNBN  MicroNucleated BiNucleate cells 
MS  Mass spectrometry 
MTD  Maximum Tolerated Dose 
NMR  Nuclear Magnetic Resonance 
No  Number 
OECD  Organisation for Economic Co-operation and Development 
PCE  PolyChromatic Erythrocytes 
(Q)SAR (Quantitative) Structure-Activity Relationship 
SCF  Scientific Committee on Food 
WHO  World Health Organisation  
 
